Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I thank too...Bring me more, pls!LOL
RoboCops..LOL!,,
430k in pre market??? How is this possible on OTC???
Napodano said that this is "BEHIND $AMBS tests blood"
Let it flow...remember 038-09...nice and easy...better this way than 30%+ and after sell off, profits taking and so on....LONG AND STRONG SGLB. GLTY!
They will need many bazoukas to bring this little monster down....almost impossible today...
And...BUM!
See ya at 0.1+ !!!
Incredibly undervalued even at 7 EUR or 8.50 USD....More revenues than VJET,less OS, great potential!!! VJET was quoted 13 USD by experts at its IPO now tradind at 33 USD... What are we talking about here?? GREAT JOB GARY!!!
Mike
Good news must keep on coming to stay above .01. This stock is highly manipulated, too many flippers and ordinary traders are afraid of it. Good to have also longs rising the flag! I hope...no, I know! that Gerald knows how to deal w/ these problems...I am longlonglong and I am sure this will be paid in full here!
Oh, not so worried, I'm very long, entered in @.04. Not plannig to get out soon...I took a breath before;)))
I am worried because it is easily manipulated...in a context of such media and good news shouldn't end red at all....
Incredibile how hard they try to put this down, hope they won't succed...
Here we go again!!!!!!!!
Amarantus Establishes LymPro Research Collaboration With Boston University School of Medicine
Download PDF
SAN FRANCISCO, Jan. 29, 2014 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS), a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today announced that it is establishing a research collaboration with researchers at Boston University School of Medicine (BUSM). The Company will work together with BUSM Professor of Neurology and Neurosurgery Dr. Robert Stern to evaluate the feasibility of using the LymPro Test ® as a blood based test to identify patients early in the disease process of the neurodegenerative diseases, chronic traumatic encephalopathy (CTE) and Alzheimer's disease (AD).
"We are pleased to be establishing this collaboration to evaluate the potential of LymPro in this emerging area of medical interest," said Gerald E. Commissiong, President and CEO of Amarantus. "While the research is early in nature, there is a strong scientific basis to believe that the cell cycle dysregulation that LymPro measures in Alzheimer's patients may have relevance to Traumatic Brain Injury and CTE. We are hopeful the information generated from this study will provide further insights for the field as we learn more about CTE."
Dr. Stern, who is the Clinical Core Director at the BU Alzheimer's Disease Center, has grant funding from the National Institutes of Health (NIH) to fund his work on developing methods of detecting and diagnosing CTE during life; this was the first grant for CTE ever funded by NIH (co-funded by the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, and the National Institute of Child Health and Human Development). As part of the study, Stern and his colleagues have already examined over 70 former NFL players and 20 same age elite non-contact sport athletes.
"Cell cycle dysregulation is an emerging area of interest in Alzheimer's disease and Traumatic Brain Injury," said Dr. Stern. "We are hopeful the data gathered from this study will inform future studies into this important and emerging field of medical science."
This is a little crazy Zoom...how you see this happened? Do you really think they will go above, at least $3 with such many shares? Not to mention about how big MC will be...I am curious to know more how you and other people you know, see this...
Good job Mase! This is something I wouldn't think of...
GOE is more than a 3d printing company and I hope people will realise that. That is why I don't understand why is not worth, at least in time, as much as known pure plays companies. We'll see... I am verry long GOE as much as in other pure play companies!!!Of course, I am also long Gary an 3DPSPremium!!
Here we go again!!
"A year from now you will wish you had started today."
- Karen Lamb
+20%+ end of day!
Soon...Step by step! Patience!
HERE WE GO! AMBS PRESS RELEASE!!!!!
You hit my point! Thank you! I am also long long long....Btw, good job!
JJ, what is your opinion about the 120mil shares sell off after 18th? If you have already express yourself, sorry for not paying enough attention!
Couldn't resist....;))
Sure they do...They won't be the only one long term...
For several days, they attack and cover the end of day...Why??;))
Groupe Gorge have contract w/ BAE SYSTEMS! Its subsidiary ECA actually...
Sorry Brik, I was just saying that is nothing new on AMBS next achivements....8k is another thing....Long live AMBS!
It's just S-1amendment, nothing new..See you all in 2014 and Happy New Year!
Marcum LLP Recognized in National Ranking of SEC Audit Firms
Firm Added to ANR's Prestigious List of "Non-Big Four National Auditing Firms"
PR Newswire
NEW YORK, May 23, 2011
NEW YORK, May 23, 2011 /PRNewswire/ -- Marcum LLP, one of the largest
independent public accounting and advisory services firms in the nation, today
announced that it has been added to the listing of "non-Big Four national
auditing firms" by Accounting News Report's (ANR) Auditor Rankings, Marcum's
first-ever addition to the prestigious national firm individual breakout
group. ANR also publishes quarterly Auditor Change Rankings which evaluate the
Big Four and the other seven national auditing firms based on their changes in
auditing publicly-traded companies for the calendar year.
"The current era of increasing regulatory scrutiny has created an undeniable
drive for auditor quality," said David Bukzin, Partner-in-Charge of the
Securities and Exchange Commission (SEC) Assurance Practice at Marcum LLP.
"Our inclusion by ANR among the nation's 'non-Big Four national auditing
firms' is validation for what our clients have known all along: that Marcum's
SEC assurance services are among the nation's best in terms of
quality-of-service, efficiency, integrity and technical expertise."
The ranking is a direct reflection of the quality of Marcum's growing
practice, the ninth largest SEC practice in the nation among the top 100 firms
according to AuditAnalytics.com. During the first quarter 2011, Marcum won
four new SEC client engagements.
This should be interesting for SGLB too...
"U.S. NEWS
U.S. Economy Begins to Hit Growth Stride
Stronger-Than-Expected Increase in GDP Fueled by Consumer Spending:
Another company stepping up spending is Honeywell International Inc. Finance chief Dave Anderson said this week that the manufacturer is likely to boost capital expenditures 30% next year, to $1.2 billion, ending several years of caution.
Mr. Anderson said the company is responding to signs of stronger growth it sees in the economy—including growing industrial production and an uptick in capital expenditures by other firms. Honeywell has already seen an upturn in order rates, he added."WSJ 20th Dec
Btw, good job JJ!
They put barricades at .056....How long can they do this...?!
Not everybody sees this live and the number of traded shares, so psychologically they are doing their job...
Is it possible to see a short squeeze? What do you think guys?
Good tip w/ the graduating thing! Maybe now is more eligible for them:)...I will try again tomorrow...Thanks for info!
GGRFG was my only problem...This is why I don't understand...I cited "is not eligible" , whatever that means for them and for me...Nevermind, don't bother anymore...Thank you anyway!
I wanted to buy GGRFG w/ Bloomberg but they said that "is not eligible". I don't know why (any idea?)...Too bad...I wish I also had US shares...I will try again in the coming days....
Solantey, can you tell where I can read such reports, please! I searched on FINRA, but I found only the reports of every 15th of the month... THANK YOU!